Comparison of the effects of preemptive acetaminophen, ibuprofen, and meloxicam on pain after separator placement: a randomized clinical trial

• Published in: Progress in orthodontics 2015-10, Vol.16 (1), p.34-34, Article 34
• Main Authors: Zarif Najafi, Hooman, Oshagh, Morteza, Salehi, Parisa, Babanouri, Neda, Torkan, Sepideh
• Format: Article
• Language: English
• Subjects: Acetaminophen - therapeutic use; Adolescent; Adult; Analgesics, Non-Narcotic - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Cyclooxygenase Inhibitors - therapeutic use; Dental Occlusion; Dentistry; Double-Blind Method; Female; Follow-Up Studies; Humans; Ibuprofen - therapeutic use; Male; Mastication - physiology; Medicine; Meloxicam; Orthodontic Appliances - adverse effects; Pain - prevention & control; Pain Measurement - methods; Pain Perception - drug effects; Premedication; Prospective Studies; Thiazines - therapeutic use; Thiazoles - therapeutic use; Young Adult
• ISSN: 2196-1042; 1723-7785; 2196-1042
• DOI: 10.1186/s40510-015-0104-y

Background This study aims to evaluate and compare the effect of pre-procedural administration of acetaminophen, ibuprofen, and meloxicam in reducing pain after separator placement. Methods Three hundred twenty-one patients who needed orthodontic treatment and aged above 15 were randomly assigned to one of the three study groups: group A: 650 mg acetaminophen, group B: 400 mg ibuprofen, and group C: 7.5 mg meloxicam. All subjects received a single dose of medication 1 h prior to separator placement. Using visual analog scale, patients recorded their pain perception during rest, fitting posterior teeth together, and chewing at time intervals of immediately, 2, 6, 24, and 48 h after separator placement. Results There was no significant difference between acetaminophen, ibuprofen, and meloxicam in post-separator placement pain control when administered 1 h before the procedure. In all the groups, at rest, pain level elevated after separator placement and reached its peak at 24 h and then subsided until 48 h. But during chewing and fitting of the posterior teeth, some of the groups reached a peak in pain at 48 h. No significant difference was found in pain experience between males and females. Conclusions Meloxicam can be used as an effective analgesic in orthodontic pain control considering it has less gastric side effects compared to the conventional nonsteroidal anti-inflammatory drugs. Trial registration Iranian Registry of Clinical Trials, IRCT2015041821828N1